What Happened?
San Diego, CA-based Genalyte Appointed Cary Gunn as Chief Executive Officer
About the Company
Since 2007, Genalyte has been guided by the vision of taking a single drop of blood, performing panels of tests and returning accurate and reproducible results within a few minutes. We launched our first instrument in 2012 in the pharmaceutical industry and academia for a range of healthcare applications including autoimmune disease monitoring, screening of cancer biomarkers, testing for infectious agents and detecting anti-drug antibodies. By reducing tests to a microscopic size in a highly multiplex environment on the surface of silicon chips we are able to generate more information from a smaller sample in less time than conventional techniques.
About the Person
Dr. Gunn currently holds 81 issued US patents, with more in process. In 2003, he was recognized by MIT Technology Review as a Top Young Innovator. In 2008, he received the Optical Society of America Adolph Lomb medal and the Berthold-Leibinger Foundation Innovation Prize. Dr. Gunn also co-founded Luxtera where he was responsible for technology development and served as CTO until 2007. Dr. Gunn received his PhD from Caltech in Electrical Engineering. Before that Dr. Gunn was an officer in the US Air Force, responsible for launching GPS satellites. He is a graduate of the US Air Force Academy.
Info Source
Press Release
Short Profile